Lighthouse Pharma Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15.2M
- Investors
-
4
Lighthouse Pharma General Information
Description
Developer of a precision medicine designed to target Alzheimer's and other diseases with unmet medical needs. The company is developing novel, potent, and selective protease inhibitors based on precision medicine for chronic degenerative and inflammatory disorders, enabling healthcare providers and patients to solve dementia, periodontal disease, atherosclerosis, and orodigestive cancers.
Contact Information
Website
www.lighthousepharma.comCorporate Office
- 8001 Redwood Boulevard
- Novato, CA 94945
- United States
Corporate Office
- 8001 Redwood Boulevard
- Novato, CA 94945
- United States
Lighthouse Pharma Timeline
Lighthouse Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 06-May-2026 | $15.2M | Completed | Clinical Trials - Phase 2 | ||
| 2. Grant | 22-Aug-2025 | Completed | Clinical Trials - Phase 2 | |||
| 1. Early Stage VC (Series A) | 01-Dec-2023 | $2.75M | $2.75M | Completed | Clinical Trials - Phase 2 |
Lighthouse Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lighthouse Pharma Signals
Lighthouse Pharma Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Double Point Ventures | Venture Capital | Minority | ||
| Marin Sonoma Impact Ventures | Venture Capital | Minority | ||
| National Institute on Aging | Government | |||
| Portfolia | Venture Capital | Minority |
Lighthouse Pharma Investments (1)
Lighthouse Pharma’s most recent deal was a Corporate Asset Purchase with Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) for . The deal was made on 27-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) | 27-Jan-2023 | Corporate Asset Purchase | Buildings and Property |
Lighthouse Pharma FAQs
-
When was Lighthouse Pharma founded?
Lighthouse Pharma was founded in 2022.
-
Where is Lighthouse Pharma headquartered?
Lighthouse Pharma is headquartered in Novato, CA.
-
What is the size of Lighthouse Pharma?
Lighthouse Pharma has 12 total employees.
-
What industry is Lighthouse Pharma in?
Lighthouse Pharma’s primary industry is Drug Discovery.
-
Is Lighthouse Pharma a private or public company?
Lighthouse Pharma is a Private company.
-
What is the current valuation of Lighthouse Pharma?
The current valuation of Lighthouse Pharma is .
-
What is Lighthouse Pharma’s current revenue?
The current revenue for Lighthouse Pharma is .
-
How much funding has Lighthouse Pharma raised over time?
Lighthouse Pharma has raised $18M.
-
Who are Lighthouse Pharma’s investors?
Double Point Ventures, Marin Sonoma Impact Ventures, National Institute on Aging, and Portfolia have invested in Lighthouse Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process